KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CareDx (CDNA) Shares Outstanding (Weighted Average) (2016 - 2026)

CareDx's Shares Outstanding (Weighted Average) history spans 14 years, with the latest figure at $51.2 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) fell 7.44% to $51.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $51.2 million, a 7.44% decrease, with the full-year FY2025 number at $53.3 million, up 0.97% from a year prior.
  • Shares Outstanding (Weighted Average) hit $51.2 million in Q1 2026 for CareDx, down from $53.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for CDNA hit a ceiling of $55.3 million in Q1 2025 and a floor of $51.2 million in Q1 2026.
  • Historically, Shares Outstanding (Weighted Average) has averaged $53.3 million across 5 years, with a median of $53.3 million in 2025.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): increased 6.91% in 2025 and later decreased 7.44% in 2026.
  • Tracing CDNA's Shares Outstanding (Weighted Average) over 5 years: stood at $53.3 million in 2022, then rose by 0.83% to $53.8 million in 2023, then decreased by 1.84% to $52.8 million in 2024, then increased by 0.97% to $53.3 million in 2025, then dropped by 4.01% to $51.2 million in 2026.
  • Business Quant data shows Shares Outstanding (Weighted Average) for CDNA at $51.2 million in Q1 2026, $53.3 million in Q4 2025, and $54.0 million in Q3 2025.